Tag: Global Biochemistry Award

Neng Jiang | Biochemistry | Best Researcher Award

Published on by Shen Awards

Dr. Neng Jiang | Biochemistry | Best Researcher Award

Sun Yat-sen University Cancer Center | China

Dr. Neng Jiang is a highly accomplished pathologist and cancer researcher, recognized for his expertise in angiogenesis and stem cell biology within the context of lung cancer. With both an MD and a Ph.D., he has established himself as a leading academic and clinical researcher at the Department of Pathology, Sun Yat-sen University Cancer Center in Guangzhou, China, one of Asia’s foremost institutions for oncology research. His career is defined by a commitment to advancing diagnostic pathology and deepening the understanding of cancer mechanisms, with a focus on bridging molecular discoveries with real-world clinical applications. Over the years, Dr. Jiang has authored multiple publications in high-impact international journals indexed in Scopus, PubMed, and Web of Science, contributing valuable knowledge to the global medical community. His ability to integrate clinical observations with experimental research has positioned him as a crucial contributor to translational oncology, enabling better strategies for early detection and targeted therapies. Through international collaborations and active engagement in academic forums, he has established a strong global presence. With a career dedicated to advancing cancer research and improving patient outcomes, Dr. Jiang exemplifies the role of a researcher whose work drives innovation, education, and clinical transformation in modern oncology.

Professional Profile

Education

Dr. Neng Jiang’s academic foundation is firmly rooted in medicine and research, reflecting his dual training as a clinician and scientist. He pursued his Doctor of Medicine (MD) with a specialization in pathology, equipping him with extensive knowledge of human disease processes and diagnostic methodologies. Following his medical degree, he undertook a Doctor of Philosophy (Ph.D.) in Oncology and Pathology, which allowed him to explore advanced mechanisms of cancer development, particularly angiogenesis and cancer stem cell biology. His Ph.D. research, conducted at Sun Yat-sen University Cancer Center, emphasized the tumor microenvironment and molecular factors influencing cancer progression, with findings that contributed to the academic literature in the field. Throughout his education, Dr. Jiang actively engaged in research activities, conference presentations, and collaborative projects, which strengthened both his theoretical and practical understanding of oncology. His commitment to academic excellence is reflected in his strong track record of publications during his doctoral studies. By combining clinical medical training with rigorous scientific inquiry, Dr. Jiang’s education uniquely prepared him to bridge the gap between laboratory research and patient care, laying the foundation for his impactful career in pathology and oncology research at national and international levels.

Professional Experience

Dr. Neng Jiang’s professional career has been characterized by his contributions to both clinical pathology and academic research. He currently serves at the Department of Pathology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, one of the most prestigious oncology research institutions in China. In this role, he has been deeply involved in diagnostic pathology while leading projects that investigate the biological basis of cancer progression. His experience extends across collaborative clinical studies, translational research, and guiding younger researchers in pathology-related investigations. Dr. Jiang has worked extensively with multidisciplinary teams, both domestically and internationally, enabling him to contribute to projects that integrate clinical practice with laboratory innovation. His professional portfolio includes participation in major research initiatives aimed at improving cancer diagnostics, treatment strategies, and biomarker discovery. He has also presented his work at leading scientific conferences, where he has shared critical insights with the global pathology and oncology community. Beyond his research and clinical commitments, Dr. Jiang plays a role in academic mentorship, training medical students and junior researchers, thereby fostering the next generation of cancer scientists. His professional journey highlights a balance of leadership, innovation, and dedication to advancing oncology.

Research Interests

Dr. Neng Jiang’s primary research interests lie at the intersection of angiogenesis, stem cell biology, and lung cancer pathology, areas that are central to understanding tumor initiation, growth, and metastasis. He has a particular focus on the molecular pathways and tumor microenvironmental factors that drive cancer progression, with the ultimate aim of developing more effective therapeutic interventions. His work explores how abnormal vascular growth supports cancer survival and how cancer stem cells contribute to resistance to therapy and recurrence. In addition to lung cancer, he has engaged in research that evaluates biomarkers for cancer diagnosis and prognosis, contributing to precision medicine approaches in oncology. Dr. Jiang’s research interests also include translational applications, where discoveries in the laboratory are applied to clinical settings, bridging the gap between basic science and patient care. By combining pathology expertise with molecular research, he aims to identify novel targets for anti-cancer therapies and improve strategies for early cancer detection. His dedication to these research areas is evident in his growing body of publications in high-impact journals and his collaborations with international experts. This focus ensures that his work continues to make meaningful contributions to both academic research and clinical oncology practice.

Research Skills

Over the course of his academic and professional career, Dr. Neng Jiang has developed an extensive range of research skills that make him highly effective in cancer pathology and translational oncology. His expertise spans both laboratory-based and clinical methodologies. He is proficient in histopathology, immunohistochemistry, molecular diagnostics, and biomarker analysis, enabling him to provide detailed insights into tumor biology. Dr. Jiang has also mastered experimental techniques related to cell culture, angiogenesis assays, and stem cell studies, which are vital for investigating mechanisms of tumor growth and resistance. Beyond laboratory skills, he has strong experience in scientific writing, data interpretation, and statistical analysis, ensuring his research is rigorous and impactful. His ability to integrate clinical observations with molecular-level data distinguishes his work and allows him to develop comprehensive approaches to cancer research. Additionally, Dr. Jiang is adept at working in multidisciplinary research environments, coordinating with oncologists, molecular biologists, and clinicians to achieve common goals. He also has experience with international research platforms, presenting findings at conferences and contributing to global scientific dialogues. These skills, combined with his clinical training, position him as a well-rounded researcher capable of delivering impactful contributions to modern oncology.

Awards and Honors

Throughout his career, Dr. Neng Jiang has received recognition for his outstanding contributions to pathology and oncology research. His awards reflect both academic excellence and research innovation. He has been acknowledged for his impactful publications in high-impact journals, many of which focus on lung cancer pathology, angiogenesis, and stem cell biology. His work has contributed to the development of novel diagnostic and therapeutic approaches, earning him recognition at both national and international scientific forums. Dr. Jiang has also been invited to present his findings at leading conferences, where his presentations have received commendation for advancing the field of oncology. In addition to publication-related achievements, he has been honored with institutional awards from Sun Yat-sen University Cancer Center, recognizing his leadership and research excellence. His active participation in academic committees and professional societies has further solidified his standing as a respected member of the scientific community. While his career continues to evolve, the honors he has already received demonstrate his capacity for innovation, his dedication to patient-centered research, and his role as a thought leader in cancer pathology. These recognitions highlight his potential for future breakthroughs and leadership in global oncology research.

Publication Top Note

  • Defining homologous recombination deficiency status in pancreatic ductal adenocarcinoma: Clinical implications for evaluating response to platinum chemotherapy — 2025

Conclusion

In conclusion, Dr. Neng Jiang is a distinguished pathologist and oncology researcher whose career reflects a remarkable blend of academic excellence, clinical expertise, and research innovation. With his dual qualifications of MD and Ph.D., he has developed an in-depth understanding of cancer biology, particularly focusing on angiogenesis and stem cell pathways in lung cancer. His research contributions, published in reputed journals and presented at international conferences, have advanced knowledge in cancer pathology and created new avenues for therapeutic strategies. Professionally, he has played a critical role at the Sun Yat-sen University Cancer Center, where he combines clinical diagnostics with pioneering research initiatives. His skills in molecular diagnostics, translational research, and scientific leadership make him a valuable contributor to both academia and clinical oncology. Recognized with multiple awards and honors, Dr. Jiang’s career demonstrates consistent excellence and a commitment to improving patient outcomes. Looking forward, his ongoing dedication to research and collaboration promises further advancements in cancer detection and treatment. These qualities make him a deserving candidate for international recognition, particularly the Best Researcher Award, as he continues to shape the future of pathology and oncology at both national and global levels.

Aurora Daniele | Biochemistry | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Aurora Daniele | Biochemistry | Best Researcher Award

University of Naples Federico II | Italy

Prof. Dr. Aurora Daniele is an accomplished academic and researcher with more than three decades of contributions to the fields of molecular biology, genetics, and biochemistry. Currently serving as a Full Professor at the Università degli Studi di Napoli “Federico II,” she has established herself as an influential figure in biomedical sciences with a broad focus ranging from enzymatic pathways and protein biosynthesis to lysosomal storage disorders and molecular diagnostics. Her career reflects a remarkable blend of academic leadership, impactful research, and international collaboration. Prof. Daniele has published extensively in top-tier journals, authoring over 136 scientific papers indexed in Scopus, Web of Science, and PubMed. With an h-index of 30 and more than 2,700 citations, her research is widely recognized and cited globally. She has collaborated with institutions such as the Mayo Clinic in the United States and played a pivotal role as Principal Investigator at CEINGE – Biotecnologie Avanzate. Beyond research, she has contributed to academic governance, serving as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli.” Through her outstanding work, Prof. Daniele has significantly advanced knowledge in life sciences while shaping the next generation of scholars and practitioners.

Professinal Profile

Scopus | ORCID

Education

Prof. Dr. Aurora Daniele’s academic journey began with a strong foundation in the life sciences. She pursued her degree in Biological Sciences at the Università degli Studi di Napoli “Federico II,” where she developed a keen interest in molecular biology, genetics, and biochemical research. Her rigorous training at this historic university provided her with both theoretical depth and practical expertise, enabling her to engage in cutting-edge research from the early stages of her career. Following her initial studies, she sought advanced scientific exposure through national and international fellowships, most notably at the Telethon Institute of Genetics and Medicine in Milan, Italy. During this formative period, she focused on molecular diagnostics, genetic regulation, and the study of metabolic pathways. These opportunities enriched her scientific outlook, broadening her expertise in clinical molecular biology and the application of advanced biotechnological methods. Her educational background, deeply rooted in one of Italy’s oldest and most prestigious institutions, provided the strong academic and research orientation that continues to guide her career today. This blend of local academic grounding and global research training has allowed Prof. Daniele to establish herself as a thought leader in genetics and molecular diagnostics.

Professional Experience

Prof. Dr. Aurora Daniele has an extensive record of academic leadership and professional achievements. She currently serves as Full Professor at the Università degli Studi di Napoli “Federico II,” where she has taught and mentored undergraduate, graduate, and doctoral students in life sciences, biochemistry, and genetics. Her professional trajectory includes notable leadership roles, such as her tenure as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli”. In addition, she has contributed significantly to clinical and translational research as Principal Investigator at CEINGE – Biotecnologie Avanzate, an advanced biotechnology research center in Naples. Her professional career has been marked by consistent efforts to integrate molecular diagnostics into clinical applications, advancing both science and healthcare. Prof. Daniele has also played an essential role in fostering collaborations with international institutions, including the Mayo Clinic in the United States, thereby broadening the impact of her research beyond Italy. As an educator and scientist, she has successfully combined laboratory innovation with academic leadership, resulting in a career that influences policy, teaching, and medical practice. Her professional achievements highlight her as a leader in Italian and international biomedical research.

Research Interests

Prof. Dr. Aurora Daniele’s research interests lie at the intersection of molecular biology, genetics, and clinical biochemistry. Her work primarily focuses on enzymatic pathways, protein biosynthesis, and the molecular mechanisms underlying lysosomal storage disorders. She has dedicated significant research efforts to understanding genetic regulation and transcriptomic responses, with particular attention to the signaling pathways involved in metabolic and degenerative diseases. Another central aspect of her research is the development and application of molecular diagnostic tools aimed at identifying genetic disorders and optimizing clinical interventions. She is equally interested in transcriptomic and proteomic studies, which provide a broader systems-level understanding of disease pathophysiology. Over the years, Prof. Daniele has expanded her research to include clinical molecular diagnostics, with an emphasis on bridging laboratory science and patient care. She has also contributed to the study of nutritional sciences, linking metabolism to molecular pathways, thereby highlighting the interplay between diet, genetics, and health outcomes. Her wide-ranging interests have allowed her to contribute meaningfully to both fundamental science and applied medicine, positioning her as a key figure in advancing knowledge in biomedicine, diagnostics, and personalized healthcare.

Research Skills

Prof. Dr. Aurora Daniele possesses a highly diverse and advanced skill set in molecular biology, biochemistry, and genetics. She is proficient in enzymatic assays, protein expression and purification techniques, and the analysis of signaling pathways critical to cellular function. Her expertise extends to transcriptomic and proteomic technologies, enabling her to study gene expression regulation and protein interactions at a systems biology level. Additionally, she has advanced skills in clinical molecular diagnostics, which she has applied in both laboratory and translational settings to improve the detection and understanding of genetic disorders. Prof. Daniele is skilled in molecular cloning, PCR, electrophoresis, and biochemical analysis of cellular mechanisms. Her research also demonstrates proficiency in developing and validating biomarkers for disease, particularly in lysosomal storage disorders. Beyond laboratory methods, she is adept at scientific writing, project leadership, and cross-disciplinary collaboration, often integrating expertise from different research domains. Her ability to combine technical precision with conceptual innovation has made her a valuable contributor to both basic and applied research. These skills, acquired over decades of work, form the backbone of her impactful contributions to modern biomedical sciences.

Awards and Honors

Throughout her career, Prof. Dr. Aurora Daniele has received recognition for her exceptional contributions to biomedical research and academic leadership. She has been consistently acknowledged for her role in advancing molecular biology and clinical biochemistry, as well as for her leadership positions within prestigious Italian universities. Serving as President of the School of Food and Nutrition Sciences at the University of Campania “L. Vanvitelli” reflects her academic excellence and administrative capabilities. Her extensive publication record, with over 136 papers indexed in Scopus, PubMed, and Web of Science, further testifies to her global recognition. With an h-index of 30 and over 2,700 citations, her influence within the scientific community is substantial. Beyond metrics, she has been invited to collaborate with international research institutions, including the Mayo Clinic, underscoring the value of her expertise in global biomedical research. While specific awards and formal honors add to her distinction, her career itself stands as a testament to sustained excellence, mentorship, and leadership. Her recognition is rooted not only in academic circles but also in her meaningful impact on advancing diagnostics, therapeutic strategies, and higher education.

Publication Top Notes

  • Exploring the role of serum adiponectin and its holigomerization in fibrotic interstitial lung diseases: results from a cross-sectional study — 2025

  • β-Hydroxybutyrate mitigates the detrimental effects of high glucose in human retinal pigment epithelial ARPE-19 cells — 2025

  • Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients — 2025

  • Plasma adiponectin levels are associated with habitual dietary polyphenol intake in individuals at high cardiometabolic risk: a cross-sectional study — 2025

  • Exploring the Link Between Psoriasis and Adipose Tissue: One Amplifies the Other — 2024 — 2 citations

  • Impact of Lifestyle Interventions on Multiple Sclerosis: Focus on Adipose Tissue — 2024 — 3 citations

  • Effects of Exhaustive Exercise on Adiponectin and High-Molecular-Weight Oligomer Levels in Male Amateur Athletes — 2024 — 1 citation

  • LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa — 2024 — 3 citations

Conclusion

Prof. Dr. Aurora Daniele exemplifies the qualities of an outstanding researcher, educator, and leader in the fields of molecular biology, genetics, and biochemistry. With a career spanning more than three decades, she has consistently contributed to advancing both fundamental science and applied clinical practices. Her extensive research output, collaborations with international institutions, and leadership roles within Italian academia reflect her ability to integrate innovation, mentorship, and governance. She has effectively bridged laboratory research with healthcare applications, particularly in molecular diagnostics and metabolic disorders, thereby enhancing both scientific understanding and patient outcomes. Her skills, ranging from enzymatic assays to proteomic studies, highlight her versatility and technical excellence, while her publication record demonstrates her influence and recognition within the global scientific community. Prof. Daniele’s dedication to education has further amplified her impact, preparing the next generation of scientists and healthcare professionals. Her professional journey underscores a balance of academic rigor, international collaboration, and scientific creativity, making her a true leader in biomedical sciences. With her ongoing research and visionary outlook, she continues to shape the future of diagnostics, molecular medicine, and higher education, deserving recognition at the highest levels.

Azam Moosavi | Biochemistry | Best Researcher Award

Published on by Shen Awards

Dr. Azam Moosavi | Biochemistry | Best Researcher Award

R&D lab Manager/supervisor of innovation center of SCARM(Stem Cell and Regenerative Medicine) from Tabriz University of Medical Sciences, Iran

Dr. Azam Moosavi is a dedicated and innovative biochemist specializing in beta-cell regeneration for the treatment of Type 1 diabetes. With a strong academic foundation and a passion for interdisciplinary research, she integrates molecular biology, regenerative medicine, and clinical biochemistry in her scientific work. Over her academic and professional career, she has developed a notable track record in research, mentorship, and laboratory management. Her research aims to translate scientific findings into real-world applications, especially for chronic diseases like diabetes. She has contributed to several peer-reviewed publications, presented at major international conferences, and co-authored a book chapter on bioactive peptides. Currently serving as R&D and Cell Culture Lab Manager at the Innovation Center of Stem Cells and Regenerative Medicine at Tabriz University of Medical Sciences, Dr. Moosavi is also actively involved in mentoring young researchers. With additional expertise in teaching, clinical laboratory operations, and scientific writing, she brings a multifaceted approach to biomedical research. Her work demonstrates both academic rigor and practical impact, and she is highly regarded for her contributions to translational medicine, epigenetics, and molecular diagnostics. Dr. Moosavi continues to strive toward scientific excellence, combining curiosity with applied innovation in pursuit of better health solutions.

Professional Profile

Education

Dr. Azam Moosavi’s academic journey reflects her deep commitment to biomedical sciences and health research. She earned her Ph.D. in Biochemistry from the Institute of Biochemistry and Biophysics (IBB) at the University of Tehran, where her thesis focused on beta-cell regeneration in Type 1 diabetes through pharmaceutical induction. Her Ph.D. was marked by an impressive GPA (3.7/4) and resulted in multiple scientific presentations and publications. Prior to that, she completed a Master of Public Health (MPH) in Health Management and Reform at Tehran University of Medical Sciences, focusing on strategic risk management in health systems. She also holds an M.Sc. in Biochemistry from Tarbiat Moallem University in Tehran, where she investigated alpha thalassemia genetics, leading to multiple congress presentations. Dr. Moosavi began her academic training with a Bachelor of Science in Clinical Laboratory Sciences from Mashhad University of Medical Sciences, followed by an Associate degree in the same field from Tehran University of Medical Sciences. Her academic record is consistent, with GPA scores ranging from 3.3 to 3.9, showcasing a solid grasp of theory and practice. These multidisciplinary qualifications equip her with a robust foundation for both laboratory research and healthcare innovation.

Professional Experience

Dr. Moosavi brings over two decades of experience spanning research, laboratory management, and academic instruction. Since March 2023, she has served as R&D and Cell Culture Lab Manager at the Innovation Center of Stem Cells and Regenerative Medicine (SCARM), Tabriz University of Medical Sciences. Here, she supervises experimental design, oversees lab operations, mentors postgraduates, and contributes to cutting-edge regenerative research. Prior to this role, Dr. Moosavi spent ten years teaching biochemistry laboratory courses to medical, dental, and pharmacy students at Alborz University of Medical Sciences. Her instruction emphasized clinical applications and hands-on skills, significantly enhancing student competency in diagnostics. Between 2005 and 2013, she managed clinical laboratories in various health centers and at Kasra Hospital in Karaj, where she was responsible for quality control, team supervision, and staff training across hematology, microbiology, and biochemistry divisions. In addition to her formal roles, she has led workshops in quality control and hematology testing, implemented risk management strategies, and participated in numerous clinical and academic projects. Her professional journey is characterized by leadership in education, hands-on expertise in diagnostics, and a drive to integrate innovative research with public health practice.

Research Interests

Dr. Moosavi’s research interests are centered on the intersection of molecular biology, regenerative medicine, and clinical diagnostics. Her primary focus is on beta-cell regeneration as a therapeutic strategy for Type 1 diabetes—a condition she explores through pharmaceutical, genetic, and immunological lenses. She is particularly interested in cell-based models, gene regulatory networks, and high-tech therapeutic interventions aimed at reversing or halting disease progression. Her passion for stem cell biology and regenerative therapies is reflected in her involvement with mesenchymal stem cell research and the use of exosomes in clinical settings. Beyond diabetes, she has contributed to projects involving autoimmune disorders, fertility research, cancer diagnostics, and infectious diseases like COVID-19. Her work also explores epigenetic regulation, as evidenced by a highly cited publication on the role of epigenetics in human diseases. In addition, Dr. Moosavi is eager to integrate new technologies into her research, including artificial intelligence (AI), next-generation sequencing (NGS), and gene editing techniques. This interdisciplinary approach allows her to not only study disease mechanisms at the molecular level but also develop actionable, personalized treatment strategies. She continuously expands her research portfolio with a strong commitment to innovation and translational impact.

Research Skills

Dr. Moosavi has cultivated a wide array of research skills that span molecular techniques, computational analysis, and laboratory management. She is proficient in essential molecular biology methods including PCR, ELISA, Western blotting, and routine clinical laboratory testing. Her expertise also includes cell culture, particularly in managing regenerative medicine labs, as well as conducting experiments on the apoptotic effects of compounds and stem cell secretome applications. In addition to wet-lab skills, she is experienced in data analysis and literature management using tools like GraphPad Prism, RevMan5, and EndNote. Her training in Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP) principles supports her ability to implement and monitor high-quality standards in laboratory settings. Moreover, she is well-versed in risk management using Failure Mode and Effects Analysis (FMEA), which she has applied to improve safety and operational efficiency in academic laboratories. With intermediate proficiency in English and basic command of German and Azerbaijani, she is also equipped for international collaboration. Altogether, her technical and analytical competencies allow her to conduct research that is both scientifically rigorous and aligned with current regulatory standards.

Awards and Honors

Dr. Azam Moosavi has received several notable recognitions throughout her academic and professional journey. She secured third place nationally in the Ph.D. entrance exam for biochemistry at the University of Tehran, reflecting her strong academic standing. Her contributions to the field of molecular biology and regenerative medicine have been acknowledged at prestigious conferences, including the Best Poster Award at the 17th National and 8th International Congress of Biochemistry and Molecular Biology in 2023. Additionally, she was selected as the first presenter in the Young Researchers’ Section at the 15th International & 21st National Congress on Quality Improvement in Clinical Laboratories in 2024. Beyond academic accolades, Dr. Moosavi holds a patent related to lung cancer antibody production using nanopharmaceutical technology, underscoring her innovation in translational research. She also earned third position in the National Industrial Innovation Competition, further recognizing her role in applied scientific development. These honors validate her dedication to excellence, whether in academic research, laboratory innovation, or public health impact. Collectively, these awards demonstrate Dr. Moosavi’s significant contributions to biomedical science and affirm her as a rising leader in the fields of biochemistry and regenerative medicine.

Conclusion

Dr. Azam Moosavi emerges as a well-qualified candidate for the Best Researcher Award, with extensive contributions to biochemistry, regenerative medicine, and clinical laboratory science. Her academic credentials, professional experience, and interdisciplinary research projects collectively demonstrate excellence in both theoretical and applied science. Through her focus on beta-cell regeneration for Type 1 diabetes, Dr. Moosavi has tackled a major public health challenge using innovative and translational approaches. Her record includes numerous peer-reviewed publications, international presentations, patents, and awards, positioning her as a leader in her field. She has also played a key role in education and mentorship, nurturing the next generation of biomedical researchers. With solid research skills, an expanding network of collaborations, and a commitment to continuous learning, Dr. Moosavi has built a career marked by impact, growth, and forward-thinking science. Moving forward, she is poised to make even greater contributions through high-impact research, interdisciplinary teamwork, and international engagement. Her profile exemplifies the qualities that the Best Researcher Award seeks to honor: intellectual rigor, practical innovation, and a drive to improve human health through science.

Publications Top Notes

  1. Beta Cell Regeneration upon Magainin and Growth Hormone Treatment as a Possible Alternative to Insulin Therapy
    Journal: FEBS Open Bio, 2023
    Authors: Azam Moosavi, Razieh Yazdanparast

  2. Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis
    Journal: Intervirology, 2022
    Author: Azam Moosavi

  3. A Systematic Review and Meta-Analysis on the Epidemiology, Causal Agents and Demographic Characteristics of Onychomycosis in Iran
    Journal: Medical Mycology, 2019
    Author: Azam Moosavi

  4. Environmental Exposure to Endotoxin and Its Health Outcomes: A Systematic Review
    Journal: Ecotoxicology and Environmental Safety, 2019
    Author: Azam Moosavi

  5. The Frequency of Fungi Isolated from the Skin and Hair of Asymptomatic Cats in Rural Area of Meshkin-shahr, Iran
    Journal: Journal de Mycologie Médicale, 2019
    Authors: A. Moosavi, R.D. Ghazvini, K. Ahmadikia, S.J. Hashemi, M. Geramishoar, M. Mohebali, M.S. Yekaninejad, H. Bakhshi, M. Khodabakhsh

  6. The Frequency and Importance of Common α-globin Gene Deletions among β-thalassemia Carriers in an Iranian Population
    Journal: Avicenna Journal of Medical Biotechnology, 2017
    Authors: A. Moosavi, A.M. Ardekani

  7. Role of Epigenetics in Biology and Human Diseases
    Journal: Iranian Biomedical Journal, 2016
    Author: Azam Moosavi

  8. Bioactive Peptides
    Publisher: CRC Press, 2021
    Author: Azam Moosavi

  9. Effect of Vitamin B6 Supplementation on Biochemical Values in Type 2 Diabetes Mellitus
    Conference: Congress on Quality Improvement in Clinical Laboratories, 2015
    Author: Azam Moosavi

 

Khalid Subhi Ibrahim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Khalid Subhi Ibrahim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Followship at University of Zakho, United Kingdom

Dr. Khalid Subhi Ibrahim, an Assistant Professor at the University of Zakho, is a distinguished researcher in biomedical sciences, specializing in diagnostic and molecular microbiology, clinical biochemistry, and microbiome analysis. With a Ph.D. from Glasgow Caledonian University, his work focuses on understanding gut bacterial communities in obesity, Type 2 diabetes, and other health conditions using cutting-edge techniques like next-generation sequencing and bioinformatics tools such as QIIME2 and PICRUSt2. He has led significant collaborations, including projects with the Massachusetts Institute of Technology (MIT) and Kiel University, Germany, and has contributed to global microbiome conservancy efforts. An Editor-in-Chief of SJUOZ and a committee member of MVIF, Dr. Ibrahim’s expertise extends to training scientists, publishing research, and presenting at international conferences. His diverse contributions reflect his commitment to advancing microbiome research and its applications in health and environmental sciences.

Professional Profile

Education

Dr. Khalid Subhi Ibrahim holds a Ph.D. in Life Sciences from Glasgow Caledonian University, UK (2013-2017), where his research focused on “Biochemical Interactions Between the Gut Microbiome and Host in Obesity/Type 2 Diabetes.” He also completed an MSc in Veterinary Pathology specializing in fish diseases at the University of Duhok, Kurdistan Region, Iraq (2006-2008), presenting a thesis on pathological studies in common carp infected with Aeromonas hydrophila. Dr. Khalid earned his Bachelor of Veterinary Medicine (Medicine and Surgery) from the same institution in 2004. Additionally, he attended a Pre-sessional English Language program at Glasgow University in 2012. Throughout his education, Dr. Khalid developed extensive expertise in microbiology, molecular diagnostics, and bioinformatics. His academic foundation reflects a robust combination of veterinary science, microbiological research, and advanced molecular techniques, forming the basis of his prolific career in microbiome studies and biomedical sciences.

Professional Experience

Dr. Khalid Subhi Ibrahim is an accomplished Assistant Professor with extensive experience in biomedical sciences, specializing in diagnostic and molecular microbiology, clinical biochemistry, and gut microbiome research. He has a strong background in utilizing advanced molecular techniques such as next-generation sequencing, bioinformatics, and 16S rRNA analysis to explore microbiota in various contexts, including obesity, Type 2 diabetes, pollution, and animal health. Dr. Ibrahim has collaborated with prestigious institutions such as Glasgow Caledonian University, Monash University, MIT, and Universitätsklinikum Schleswig-Holstein on numerous international projects. His expertise extends to training scientists, supervising research students, and contributing to impactful research. Additionally, he has served as Editor-in-Chief of the SJUOZ journal and actively participated in global microbiome conservancy initiatives. With a proven track record of research, teaching, and collaboration, Dr. Ibrahim is dedicated to advancing microbiome science and fostering academic excellence.

Research Interest

Dr. Khalid Subhi Ibrahim’s research interests focus on biomedical sciences, with expertise in diagnostic and molecular microbiology, clinical biochemistry, and bioinformatics. His work centers on understanding the role of gut microbiome changes in health and disease, particularly in obesity, Type 2 diabetes mellitus (T2DM), and pollution. Employing advanced molecular techniques and next-generation sequencing, he investigates microbiota in humans, animals, soils, and wastewater, emphasizing 16S rRNA analysis using tools like QIIME2 and PICRUSt2. Dr. Ibrahim’s research extends to metagenomics and functional analysis of microbiomes in various contexts, including colorectal cancer, nosocomial infections in children, and zoonotic diseases in livestock. His collaborations span globally, engaging with institutions such as MIT, Universitätsklinikum Schleswig-Holstein, and the University of Tartu. Driven by a passion for microbiome research, he aims to advance in silico analysis techniques, enriching the understanding of microbial ecosystems and their impacts on human and environmental health.

Award and Honor

Dr. Khalid Subhi Ibrahim, a distinguished microbiologist and academic, has earned recognition for his remarkable contributions to biomedical sciences, particularly in microbiome research. Serving as Assistant Professor at the University of Zakho, Dr. Ibrahim leads the Global Microbiome Conservancy in Iraq and holds the prestigious position of Editor-in-Chief for the Scientific Journal of University of Zakho (SJUOZ). His collaborative endeavors span globally, involving partnerships with renowned institutions such as MIT, Universitätsklinikum Schleswig-Holstein, and Monash University. Dr. Ibrahim’s accolades include delivering impactful presentations at international conferences and publishing high-impact research on gut microbiota’s role in obesity, Type 2 diabetes, and pollution. His expertise in bioinformatics and next-generation sequencing has advanced the understanding of microbial communities in diverse ecosystems. Committed to mentorship and innovation, Dr. Ibrahim’s career reflects a dedication to advancing scientific knowledge and fostering international collaboration in microbiome science.

Conclusion

Dr. Khalid Subhi Ibrahim is a distinguished researcher with expertise in diagnostic and molecular microbiology, clinical biochemistry, and microbiome analysis. His extensive academic and professional journey reflects a strong commitment to advancing biomedical sciences, with a particular focus on gut microbiome research in relation to obesity, Type 2 diabetes, pollution, and colorectal cancer. Dr. Ibrahim’s collaborative projects with esteemed institutions, including MIT and the University of Tartu, underscore his global impact and research network. His proficiency in cutting-edge techniques such as next-generation sequencing, bioinformatics, and microbiota analysis highlights his technical expertise. Additionally, his dedication to knowledge dissemination through teaching, supervising, and publishing further solidifies his contributions to science. While Dr. Ibrahim’s focus on microbiome studies is commendable, expanding his publication record in high-impact journals would further strengthen his academic influence. Overall, Dr. Khalid Subhi Ibrahim demonstrates exceptional merit as a candidate for the Best Researcher Award.

Publications Top Noted

  1. Title: Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
    Authors: Naghavi, M., Ong, K.L., Aali, A., Wool, E.E., Murray, C.J.L.
    Year: 2024
    Citations: 259
  2. Title: Retrospective analysis of pediatric sepsis and the burden of antimicrobial resistance in Duhok, Kurdistan Region of Iraq
    Authors: Ibrahim, D.R., Saadi, A.T., Yahya, N.B., Alarsalani, B.K., Ibrahim, K.S.
    Year: 2024
    Citations: 0
  3. Title: Global Burden of Cardiovascular Diseases and Risks, 1990-2022
    Authors: Mensah, G.A., Habtegiorgis Abate, Y., Abbasian, M., Murray, C.J.L., Roth, G.A.
    Year: 2023
    Citations: 295
  4. Title: Chinese medicine, Qijudihuang pill, mediates cholesterol metabolism and regulates gut microbiota in high-fat diet-fed mice, implications for age-related macular degeneration
    Authors: Cao, Y., Ibrahim, K.S., Li, X., Craft, J.A., Shu, X.
    Year: 2023
    Citations: 0
  5. Title: Molecular Characterization of Extended Spectrum β-Lactamase (ESBL) and Virulence Gene-Factors in Uropathogenic Escherichia coli (UPEC) in Children in Duhok City, Kurdistan Region, Iraq
    Authors: Hasan, S.M., Ibrahim, K.S.
    Year: 2022
    Citations: 5
  6. Title: In silico analysis of bacterial metabolism of glutamate and GABA in the gut in a rat model of obesity and type 2 diabetes
    Authors: Ibrahim, K.S., Bourwis, N., Dolan, S., Craft, J.A.
    Year: 2022
    Citations: 2
  7. Title: Effect of a TSPO ligand on retinal pigment epithelial cholesterol homeostasis in high-fat fed mice, implication for age-related macular degeneration
    Authors: Biswas, L., Ibrahim, K.S., Li, X., Craft, J., Shu, X.
    Year: 2021
    Citations: 16
  8. Title: Transcriptome-wide changes associated with the reproductive behaviour of male guppies exposed to 17α-ethinyl estradiol
    Authors: Saaristo, M., Craft, J.A., Tyagi, S., Ibrahim, K.S., Wong, B.B.M.
    Year: 2021
    Citations: 8
  9. Title: Prevalence and Hemato-biochemical Studies on Theileriosis in Naturally Infected Cattle in Erbil Province
    Authors: Aziz, K., Qader, N., Ibrahim, K.
    Year: 2021
    Citations: 3
  10. Title: Etifoxine reverses weight gain and alters the colonic bacterial community in a mouse model of obesity
    Authors: Ibrahim, K.S., Craft, J.A., Biswas, L., Spencer, J., Shu, X.
    Year: 2020
    Citations: 15

 

 

ANDREA GOBBO | Biochemistry | Best Researcher Award

Published on by Shen Awards

Ms. ANDREA GOBBO | Biochemistry | Best Researcher Award

Research Scientist at Sciensano, Belgium

Andrea Gobbo, MSc, is a research scientist specializing in health and environmental sciences, with over three years of experience in molecular biology. She holds an MSc in Chemical Sciences with a focus on biochemistry and molecular biology, graduating cum laude. Andrea has demonstrated expertise in developing and validating genomic methods such as qPCR and ddPCR for national and European Union (EU) projects related to antimicrobial resistance (AMR), genetically modified organisms (GMOs), and food/feed additives. Her contributions to scientific research are reflected in eight peer-reviewed publications, including one as the first author. In addition to research, Andrea actively mentors students in laboratory techniques and contributes to team-building activities, underscoring her commitment to collaboration and knowledge sharing. Her professional experience spans method validation, project management, and scientific communication, with proven skills in laboratory operations and data analysis. Fluent in French, English, and Dutch, Andrea is well-equipped to engage with diverse teams on global research initiatives. Her dedication to advancing health and environmental science makes her an exemplary candidate for recognition in her field.

Professional Profile

Education

Andrea Gobbo completed her Bachelor’s and Master’s degrees in Chemical Sciences at the Université Libre de Bruxelles. Her undergraduate studies, conducted from 2015 to 2019, included a thesis titled “Abundance of Chemical Elements in the Solar System,” highlighting her early interest in scientific inquiry. Graduating cum laude in 2021, Andrea’s Master’s program focused on biochemistry and molecular biology. During this time, she conducted a six-month internship for her Master’s thesis, where she explored the aggregation kinetics of amyloid beta peptide mutants related to Alzheimer’s disease. Her dedication to academic excellence is evident through her rigorous coursework and research, which provided her with a solid foundation in molecular biology techniques. This academic journey laid the groundwork for her transition into impactful professional roles in the field of health and environmental sciences.

Professional Experience

Andrea Gobbo’s professional career is marked by progressive roles at Sciensano, Belgium’s leading health and research institute. From 2022 to 2024, she served as a junior scientist, contributing to developing and validating qPCR and ddPCR methods for national and EU projects. Promoted to scientist in 2024, Andrea now leads molecular biology research for projects aimed at improving human, animal, and environmental health. Her responsibilities include drafting SOPs, mentoring students, and presenting findings at national scientific events. Andrea’s work spans numerous projects, including AMR gene detection in wastewater, GMO identification in food and feed, and DNA analysis for probiotics and vitamins. Her expertise in method validation and project management has been integral to these projects’ success. Additionally, her internship experiences at Sciensano and the Université Libre de Bruxelles further honed her technical and analytical skills in molecular biology.

Research Interests

Andrea Gobbo’s research interests lie at the intersection of molecular biology, health, and environmental sciences. She is particularly passionate about developing and validating genomic methods to address pressing global challenges, such as antimicrobial resistance (AMR) and food safety. Her work focuses on using innovative techniques, including qPCR, ddPCR, and whole-genome sequencing, to detect and quantify genetic markers in various samples, ranging from wastewater to food products. Andrea is also intrigued by applying molecular biology to monitor and control genetically modified organisms (GMOs) and pathogens in environmental and clinical settings. Her commitment to advancing public health through cutting-edge research drives her involvement in interdisciplinary projects that bridge science, policy, and societal needs.

Research Skills

Andrea Gobbo possesses a comprehensive skill set in molecular biology, including advanced techniques like qPCR, ddPCR, and multiplexing. Her expertise extends to DNA/RNA extraction, quantification, and sequencing preparation using state-of-the-art technologies such as Sanger, Illumina, and Oxford Nanopore. Andrea is adept at bacterial and fungal culture, DNA walking, agarose gel electrophoresis, and quality control methods like TapeStation analysis. Her experience in working under ISO 17025 accreditation ensures adherence to high-quality standards in laboratory practices. Beyond technical skills, Andrea excels in data analysis, problem-solving, and critical thinking, making her proficient in designing and validating complex genomic assays. She is also skilled in using bioinformatic tools like Primer3, BLAST, and laboratory instrument software, enhancing her ability to interpret and analyze genomic data effectively.

Awards and Honors

While specific awards and honors are not explicitly listed in her profile, Andrea Gobbo’s professional trajectory and achievements reflect a high standard of excellence. Graduating cum laude in her Master’s program demonstrates her dedication to academic success. Her rapid progression from a junior scientist to a lead scientist at Sciensano highlights her outstanding contributions to the field of molecular biology. Additionally, her selection to present at national scientific events and her role as a first author in a peer-reviewed publication underscore her recognition as a valuable researcher. These accomplishments position Andrea as a potential candidate for prestigious awards in health and environmental sciences.

Conclusion

Andrea Gobbo is a highly skilled and dedicated researcher whose work in molecular biology significantly contributes to health and environmental sciences. With a strong educational background, a robust publication record, and proven expertise in genomic method development, Andrea embodies the qualities of a leading scientist. Her ability to manage projects, mentor students, and collaborate effectively demonstrates her commitment to advancing scientific research and fostering teamwork. While further leadership in large-scale projects and greater international recognition could enhance her profile, Andrea’s achievements to date make her an exemplary candidate for the Best Researcher Award.

Publication Top Notes

  1. Development of a real-time PCR marker targeting a new unauthorized genetically modified microorganism producing protease identified by DNA walking
    Authors: MA Fraiture, A Gobbo, U Marchesi, D Verginelli, N Papazova, …
    Journal: International Journal of Food Microbiology
    Year: 2021
    Citation count: 13
  2. Development of a droplet digital PCR to monitor SARS-CoV-2 omicron variant BA.2 in wastewater samples
    Authors: LAE Van Poelvoorde, C Picalausa, A Gobbo, B Verhaegen, M Lesenfants, …
    Journal: Microorganisms
    Year: 2023
    Citation count: 5
  3. Development of a Taxon-Specific Real-Time PCR Method Targeting the Bacillus subtilis Group to Strengthen the Control of Genetically Modified Bacteria in …
    Authors: MA Fraiture, A Gobbo, N Papazova, NHC Roosens
    Journal: Fermentation
    Year: 2022
    Citation count: 5
  4. Pilot market surveillance of GMM contaminations in alpha-amylase food enzyme products: A detection strategy strengthened by a newly developed qPCR method targeting a GM …
    Authors: MA Fraiture, A Gobbo, C Guillitte, U Marchesi, D Verginelli, J De Greve, …
    Journal: Food Chemistry: Molecular Sciences
    Year: 2024
    Citation count: 2
  5. Development and validation of a ddPCR assay to detect and quantify tobacco DNA in smoke and smokeless tobacco and tobacco-free products
    Authors: MA Fraiture, A Gobbo, C Guillitte, S Barhdadi, C Gau, P Philipp, L Marmin, …
    Journal: Heliyon
    Year: 2024
    Citation count: 1
  6. Strategy to develop and validate digital droplet PCR methods for global antimicrobial resistance wastewater surveillance
    Authors: A Gobbo, MA Fraiture, L Van Poelvoorde, SCJ De Keersmaecker, …
    Journal: Water Environment Research
    Year: 2024
  7. Development of a reverse transcriptase digital droplet polymerase chain reaction-based approach for SARS-CoV-2 variant surveillance in wastewater
    Authors: LAE Van Poelvoorde, A Gobbo, SJD Nauwelaerts, B Verhaegen, …
    Journal: Water Environment Research
    Year: 2024
  8. Development of a Taxon-Specific Real-Time Polymerase Chain Reaction Method to Detect Trichoderma reesei Contaminations in Fermentation Products
    Authors: MA Fraiture, A Gobbo, N Papazova, NHC Roosens
    Journal: Fermentation
    Year: 2023

 

 

Lan Hong | Biochemistry | Best Researcher Award

Published on by Shen Awards

Prof. Lan Hong | Biochemistry | Best Researcher Award

Professor at Yanbian University, China

Dr. Lan Hong, a Professor in the Department of Physiology and Pathophysiology at Yanbian University’s College of Medicine, has dedicated her career to advancing knowledge in cardiovascular physiology, with a specialized focus on cardiac protection mechanisms and stem cell therapy. With over 18 years of experience, Dr. Hong’s research addresses critical challenges in cardiovascular health, particularly in understanding and treating ischemia-reperfusion injuries and myocardial infarction. She has made substantial contributions to the field through high-impact publications, collaborative research initiatives, and conference presentations. As a recognized figure in her field, she has also served as a visiting scholar at Texas A&M University-Commerce, where she expanded her work on regenerative medicine, specifically focusing on cardiac-induced RNA and pluripotent stem cells. Dr. Hong’s research is well-cited, with an H-index of 10 and a citation count of over 300, reflecting her influence in cardiac physiology research. Her extensive involvement in academic conferences, journal reviews, and mentoring has bolstered her reputation as a leader in cardiovascular research. She is also recognized through multiple awards and invitations to present her research, which underscores her commitment to advancing the understanding and treatment of cardiovascular diseases.

Professional Profile

Education

Dr. Lan Hong’s educational journey is anchored in her commitment to understanding the intricacies of cardiovascular physiology. She earned her PhD in Physiology from Yanbian University in 2012, where she also completed her MSc in the same field in 2009. Prior to her postgraduate studies, she graduated with a degree in Clinical Medicine from Yanbian University in 2006, which laid the foundation for her subsequent research in cardiac health. Her academic path reflects a deep specialization in cardiac physiology, particularly in exploring protective mechanisms for the heart and developing innovative treatments for cardiovascular diseases. Throughout her education, Dr. Hong cultivated a robust theoretical and practical understanding of physiology, providing a strong foundation for her later research on myocardial infarction and stem cell therapy. Her scholarly background, coupled with hands-on experience in clinical medicine, has greatly enriched her approach to research, enabling her to bridge the gap between theoretical knowledge and clinical application in her ongoing studies.

Professional Experience

Dr. Lan Hong has built a distinguished career as a cardiovascular researcher, currently serving as a Professor at the College of Medicine at Yanbian University, where she has worked since 2013. She initially joined the university’s Department of Physiology and Pathophysiology as an Assistant Professor, where her research began to focus on ischemia-reperfusion injury and cardiac fibrosis mechanisms. Her career includes international experience as a visiting scholar and postdoctoral researcher at Texas A&M University-Commerce from 2017 to 2018. During her tenure there, she collaborated on groundbreaking work using cardiac-inducing RNA and stem cell technology for post-infarction heart repair. Dr. Hong’s role as an educator and mentor is integral to her professional experience, as she has supervised graduate students, organized research conferences, and contributed as a reviewer for respected journals. Her professional trajectory reflects a consistent dedication to advancing cardiovascular health and supporting academic development in her field, cementing her reputation as a respected academic and researcher in cardiovascular physiology.

Research Interests

Dr. Lan Hong’s research interests center on cardiovascular physiology, with a particular emphasis on mechanisms of cardiac protection and regeneration. Her work seeks to address key challenges in treating myocardial infarction and mitigating ischemia-reperfusion injury. One of her primary research interests is exploring molecular pathways such as the Sirt1/Nrf2/ATF3/4 axis and the role of ferroptosis in cardiac injury. Additionally, Dr. Hong is committed to advancing stem cell therapy, specifically investigating the regenerative potential of induced pluripotent stem cells in cardiac repair. Her studies also delve into the role of long non-coding RNAs (lncRNAs) in modulating cellular responses to injury and in promoting cardiomyocyte regeneration. By targeting these cellular pathways, Dr. Hong aims to develop novel therapeutic approaches that offer improved outcomes for patients with cardiovascular conditions. Her research interests reflect a balanced approach that combines molecular biology, regenerative medicine, and clinical application, making significant strides in cardiovascular health advancements.

Research Skills

Dr. Lan Hong’s research skills are rooted in a robust knowledge of cardiovascular physiology, paired with technical expertise in cellular and molecular biology techniques. She is proficient in various lab methodologies essential to cardiac physiology research, including in vitro and in vivo models for studying ischemia-reperfusion injury and myocardial infarction. Dr. Hong’s work with stem cells, particularly induced pluripotent stem cells, requires advanced skills in cellular reprogramming and RNA-mediated gene expression techniques. Her proficiency extends to molecular techniques such as Western blotting, immunohistochemistry, and real-time PCR, which she utilizes to investigate gene expression patterns and protein signaling in cardiac tissues. Her ability to perform complex experimental procedures, analyze data critically, and interpret results within the context of cardiovascular health has made her research impactful and well-regarded. Dr. Hong’s research skills are complemented by her collaborative approach, which has facilitated cross-disciplinary studies and allowed her to mentor students effectively, contributing to the next generation of cardiovascular researchers.

Awards and Honors

Throughout her career, Dr. Lan Hong has received recognition for her contributions to cardiovascular research. Her work has earned her multiple awards, reflecting her expertise and influence in cardiac physiology. She has been invited to present her findings at national and international conferences, showcasing her research on ischemia-reperfusion injury and stem cell therapy. Her role as an invited speaker demonstrates the high regard in which her peers hold her work and highlights her contributions to advancing cardiovascular health. Additionally, Dr. Hong’s editorial and peer-review roles for respected journals underscore her commitment to maintaining rigorous standards in scientific research and her influence in the academic community. Her research achievements, high-impact publications, and the positive impact of her mentorship have solidified her standing as a leader in cardiovascular physiology. Her recognition through these awards and honors underscores her dedication to her field and highlights her impact on the scientific understanding of cardiac health and disease.

Conclusion

Lan Hong’s extensive research and contributions in cardiovascular physiology, along with her impactful publications, make her a strong candidate for the Best Researcher Award. Her international experience, academic achievements, and innovative work in cardiac protection mechanisms are commendable. Addressing minor gaps in industry collaboration and expanding her professional presence may further strengthen her profile for future recognitions. Overall, her dedication to advancing cardiovascular health and her achievements make her highly deserving of the award.

Publications Top Notes

  1. Synthesis and antibacterial evaluation of rhodanine-based 5-aryloxy pyrazoles against selected methicillin-resistant and quinolone-resistant Staphylococcus aureus (MRSA and QRSA)”
    Authors: MX Song, CJ Zheng, XQ Deng, LP Sun, Y Wu, L Hong, YJ Li, Y Liu, …
    Journal: European Journal of Medicinal Chemistry, 60, 376-385
    Year: 2013
    Citations: 57
  2. “MAPK and PI3K pathways regulate hypoxia-induced atrial natriuretic peptide secretion by controlling HIF-1 alpha expression in beating rabbit atria”
    Authors: Q Zhang, B Cui, H Li, P Li, L Hong, L Liu, D Ding, X Cui
    Journal: Biochemical and Biophysical Research Communications, 438 (3), 507-512
    Year: 2013
    Citations: 38
  3. “Atrial natriuretic peptide prevents the mitochondrial permeability transition pore opening by inactivating glycogen synthase kinase 3β via PKG and PI3K in cardiac H9c2 cells”
    Authors: L Hong, J Xi, Y Zhang, W Tian, J Xu, X Cui, Z Xu
    Journal: European Journal of Pharmacology, 695 (1-3), 13-19
    Year: 2012
    Citations: 37
  4. “Synthesis and biological evaluation of 5-aryloxypyrazole derivatives bearing a rhodanine-3-aromatic acid as potential antimicrobial agents”
    Authors: CJ Zheng, MX Song, LP Sun, Y Wu, L Hong, HR Piao
    Journal: Bioorganic & Medicinal Chemistry Letters, 22 (23), 7024-7028
    Year: 2012
    Citations: 35
  5. “Synthesis and positive inotropic activity of N-(4, 5-dihydro-[1, 2, 4] triazolo [4, 3-a] quinolin-7-yl)-2-(piperazin-1-yl) acetamide derivatives”
    Authors: CB Zhang, X Cui, L Hong, ZS Quan, HR Piao
    Journal: Bioorganic & Medicinal Chemistry Letters, 18 (16), 4606-4609
    Year: 2008
    Citations: 26
  6. “Adenosine A2 receptor activation ameliorates mitochondrial oxidative stress upon reperfusion through the posttranslational modification of NDUFV2 subunit of complex I in the heart”
    Authors: J Xu, X Bian, Y Liu, L Hong, T Teng, Y Sun, Z Xu
    Journal: Free Radical Biology and Medicine, 106, 208-218
    Year: 2017
    Citations: 22
  7. “Ethanol attenuates sensory stimulus-evoked responses in cerebellar granule cells via activation of GABAA receptors in vivo in mice”
    Authors: G Wu, H Liu, J Jin, L Hong, Y Lan, CP Chu, DL Qiu
    Journal: Neuroscience Letters, 561, 107-111
    Year: 2014
    Citations: 19
  8. “Ouabain stimulates atrial natriuretic peptide secretion via the endothelin-1/ETB receptor-mediated pathway in beating rabbit atria”
    Authors: L Liu, L Hong, L Yu, H Li, D Ding, S Jin, X Cui
    Journal: Life Sciences, 90 (19-20), 793-798
    Year: 2012
    Citations: 16
  9. “Cathepsins in the extracellular space: Focusing on non-lysosomal proteolytic functions with clinical implications”
    Authors: H Wang, A Inoue, Y Lei, H Wu, L Hong, XW Cheng
    Journal: Cellular Signalling, 103, 110531
    Year: 2023
    Citations: 13

 

Dr. Florence Back | Biochemistry | Best Researcher Award

Published on by Shen Awards

Dr. Florence Back | Biochemistry | Best Researcher Award

Doctorate at University of Lille, France

Florence Back is a distinguished biomaterials scientist and researcher specializing in bioadhesive and smart wound-healing technologies. Based in Strasbourg, France, she has made significant strides in developing innovative materials for medical applications, including hydrogels and electronic patches for therapeutic uses. Florence’s work is underpinned by advanced training in in vivo procedures and applied chemistry, making her well-versed in both the laboratory synthesis of biomaterials and preclinical surgical applications. Her research has been published in reputable journals, highlighting her commitment to advancing the fields of bioengineering and regenerative medicine. Florence’s research integrates expertise across biology, chemistry, and physics, emphasizing both material functionality and patient-centered applications. She has been involved in collaborative research at prestigious institutions, including CNRS Lille and UC Louvain, and is actively expanding her interdisciplinary contributions to wound care, tissue repair, and bioengineering.

Professional Profile

Education

Florence holds a Ph.D. in Biomaterials from UNISTRA Strasbourg, completed in 2022, where she focused on the synthesis and development of bioadhesives based on gelatin and catechol. This work involved extensive research into the formulation, spectroscopic characterization, and rheological analysis of these bioadhesives. Her doctoral studies were preceded by two specialized master’s degrees, both from UNISTRA Strasbourg, in supramolecular and macromolecular chemistry, completed in 2020 and 2019, respectively. Florence’s master’s education covered advanced techniques in organic and polymer synthesis, including the creation of fluorescent molecules and polymers with unique biochemical properties. Her academic journey includes a series of certifications in in vivo procedures from CNRS Lille, where she developed critical surgical skills required for research involving animal models. Florence’s education has been integral in building her comprehensive understanding of biomaterials and in vivo applications, positioning her as a skilled researcher in medical and chemical sciences.

Professional Experience

Florence’s professional experience includes postdoctoral research and engineering roles focused on advancing biomaterial applications in medicine. Currently, she is a postdoctoral researcher at UC Louvain in Belgium, working on the AI-SWEEP-2 project, which involves the synthesis of electronic patches for smart bandages intended for human use. Prior to this, she served as a biomaterials engineer at CNRS Lille, where she contributed to the ANR Gskin project, focusing on synthesizing and characterizing hydrogels doped with extracellular vesicles for diabetic wound healing. From 2020 to 2022, during her Ph.D. at the Dental Faculty of Strasbourg, Florence specialized in the synthesis of bioadhesives based on gelatin and catechol, marking the beginning of her notable contributions to biomaterials science. These roles have allowed her to develop an integrated approach to material synthesis, characterization, and biological application, emphasizing her commitment to innovation in therapeutic and regenerative materials.

Research Interests

Florence’s research interests center on biomaterials, bioadhesives, and smart wound-healing technologies. Her primary focus is the development and synthesis of bioadhesive hydrogels, which hold promise in tissue repair and regenerative medicine. Additionally, her work extends to smart bandages, integrating electronic patches for wound monitoring and therapeutic delivery, aimed at improving patient outcomes in wound care. She is also interested in the extraction and application of extracellular vesicles in biomaterials, with specific attention to their role in promoting cellular viability and tissue regeneration. Florence’s research leverages a multidisciplinary approach, combining chemistry, biology, and materials science to create innovative solutions that bridge the gap between synthetic materials and biological functions. Her commitment to research that addresses clinical challenges underscores her dedication to advancing biomaterials for direct medical applications.

Research Skills

Florence’s research skills encompass a wide range of laboratory and analytical techniques, particularly in chemistry, biology, and materials science. She is proficient in organic and polymer synthesis, including gel formulation and the development of bioadhesive materials from gelatin, chitosan, and silk hydrogels. Her technical skills include chromatography, spectroscopy (NMR, IR, UV-Vis), and nanoparticle tracking analysis, which she applies in the characterization of synthesized materials. Florence is also skilled in in vivo procedures, certified for surgeries and techniques on various animal models, such as vascular catheterization, cerebral ischemia, and renal grafting. Additionally, her experience extends to cell culture, viability testing, and supervising research protocols. Florence’s ability to conduct comprehensive material characterization combined with her surgical training in vivo highlights her versatility and readiness to bridge laboratory research with applied medical sciences.

Awards and Honors

Florence has achieved various recognitions that reflect her dedication to research excellence in biomaterials. Her doctoral research at UNISTRA Strasbourg earned her acclaim for creating bioadhesive formulations with potential applications in tissue engineering and wound care. Her work has been published in notable journals, including Frontiers in Materials and Gels, indicating her research’s value to the academic and clinical communities. Florence’s role in collaborative projects, such as the ANR Gskin and AI-SWEEP-2, highlights her contributions to interdisciplinary research initiatives aimed at developing innovative therapeutic technologies. Additionally, her certifications in in vivo procedures from CNRS Lille are a testament to her commitment to ethical and skillful research practices. Florence’s career trajectory, marked by research achievements and collaborative contributions, positions her as a promising candidate for awards in scientific innovation and applied biomaterials.

Conclusion

Florence Back demonstrates strong candidacy for a “Best Researcher Award” due to her advanced technical skills in biomaterials, substantial in vivo training, and impactful research in bioadhesives and smart bandage technologies. By addressing minor language skills and pursuing independent research initiatives, she could amplify her contributions and influence in the field.

Publication Top Notes

  1. Optimization of the Elasticity and Adhesion of Catechol- or Dopamine-Loaded Gelatin Gels under Oxidative Conditions
    • Authors: F. Back, E. Mathieu, C. Betscha, Y. Arntz, V. Ball
    • Journal: Gels
    • Year: 2022
    • Volume & Issue: 8(4), Article 210
    • Citations: 7
    • Open Access: Yes
  2. Influence of the NaIO₄ Concentration on the Gelation and the Adhesive Strength of Pyrocatechol/Pyrogallol Containing Gelatin Hydrogels
    • Authors: F. Back, V. Ball, Y. Arntz
    • Journal: Frontiers in Materials
    • Year: 2021
    • Volume & Article: 8, Article 671451
    • Citations: 4
    • Open Access: Yes

 

 

Mohammad Sadegh Hashemzadeh | Biochemistry |Best Researcher Award

Published on by Shen Awards

Assist Prof Dr. Mohammad Sadegh Hashemzadeh | Biochemistry |Best Researcher Award

Assist. Professor at Nanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Dr. Mohammad Sadegh Hashemzadeh is an accomplished Assistant Professor at Baqiyatallah University of Medical Sciences, specializing in Medical and Nano Biotechnology. He holds a Ph.D. in Nano Biotechnology, with a focus on recombinant protein production for therapeutic applications, including cell therapy for rheumatoid arthritis. Dr. Hashemzadeh has received numerous accolades, including top ranks in his B.Sc., M.Sc., and Ph.D. studies, and has published extensively in reputable journals on topics such as nanotechnology, viral protein production, and cancer treatment. His research expertise spans molecular genetics, genetic engineering, and the development of novel diagnostic methods for biological threats. Dr. Hashemzadeh’s contributions to the field are recognized internationally, making him a prominent figure in biotechnology research, particularly in Iran. His work bridges the gap between cutting-edge biotechnology and practical medical applications, reflecting his dedication to advancing health sciences.

Profile

Education

Dr. Mohammad Sadegh Hashemzadeh boasts an exemplary educational background in biotechnology and medical sciences. He began his academic journey with a Bachelor of Science (B.Sc.) degree, graduating with top honors and consistently ranking first among his peers. Driven by his passion for advanced research, Dr. Hashemzadeh pursued a Master of Science (M.Sc.) degree, where he continued to excel academically and was recognized for his outstanding performance. He then attained his Ph.D. in Nano Biotechnology from Baqiyatallah University of Medical Sciences, a prestigious institution in Iran, where he focused on recombinant protein expression and the application of nanotechnology in medical diagnostics. Following his doctoral studies, Dr. Hashemzadeh undertook postdoctoral research at the Pasteur Institute of Iran, specializing in innovative cell therapy techniques for rheumatoid arthritis. Throughout his education, he has received numerous accolades, including the first prize at the 15th International Congress of Microbiology, underscoring his dedication and excellence in the field. His comprehensive education has provided him with a solid foundation in molecular genetics, genetic engineering, and cutting-edge biotechnological methodologies.

Professional Experience

Dr. Mohammad Sadegh Hashemzadeh is an accomplished Assistant Professor at Baqiyatallah University of Medical Sciences, Tehran, Iran, with a strong background in Medical and Nano Biotechnology. His expertise spans molecular genetics, genetic engineering, and cell culture, focusing on producing recombinant proteins for therapeutic applications. Dr. Hashemzadeh’s research interests include cell therapy for rheumatoid arthritis, recombinant protein production, and viral vector engineering. He has completed a Post-Doc in cell therapy of inflammatory diseases and has been involved in various research projects, including the construction of recombinant viruses and the development of viral-like particles (VLPs) for potential therapeutic use. In addition to his research contributions, Dr. Hashemzadeh is an experienced educator, having taught courses in genetics, immunology, and nanotechnology at both undergraduate and postgraduate levels. His professional achievements are further underscored by his numerous publications in high-impact journals and his recognition through several awards and honors.

Research Interest

Dr. Mohammad Sadegh Hashemzadeh’s research interests primarily focus on the intersection of medical biotechnology and nano-biotechnology. His work spans the development of advanced therapeutic applications, particularly in molecular genetics, genetic engineering, and cell therapy for inflammatory diseases like rheumatoid arthritis. He is deeply engaged in the production of recombinant proteins, utilizing cell culture techniques to develop viral vectors and virus-like particles (VLPs) for potential cancer treatments and vaccine development. His research also includes exploring the role of peptide nucleic acids (PNAs) in detecting and treating diseases caused by biological threat agents. Additionally, Dr. Hashemzadeh investigates the application of oncolytic viruses in cancer therapy and the development of novel diagnostic methods using nanotechnology. His work is aimed at translating cutting-edge biotechnological advancements into practical solutions for complex medical challenges, contributing to the fields of virology, immunology, and therapeutic protein production.

Research Skills

Dr. Mohammad Sadegh Hashemzadeh possesses a diverse and advanced skill set in the field of biotechnology and nanotechnology. His expertise encompasses molecular genetics, genetic engineering, and cell culture, with a focus on producing recombinant proteins for therapeutic applications. His research is distinguished by his proficiency in the development and application of viral vectors and protein-based vaccines, particularly in the context of cell therapy and vaccine production. Dr. Hashemzadeh has extensive experience in the expression, solubilization, and purification of recombinant proteins, utilizing techniques such as real-time PCR and nanotechnology for diagnostic and therapeutic purposes. His work involves the synthesis and characterization of nanomaterials and viral-like particles (VLPs), contributing to advancements in diagnostic methods and biological threat detection. His skills are supported by a robust publication record in international journals, reflecting his significant contributions to the fields of molecular biotechnology and medical research.

Award and Recognition

Dr. Mohammad Sadegh Hashemzadeh has garnered notable recognition for his exceptional contributions to the fields of biotechnology and nanotechnology. His academic journey is marked by distinguished achievements, including being first-ranked among his peers during his MSc and PhD studies, and receiving accolades such as the First Prize at the 15th International Congress of Microbiology in 2014. His innovative research has been published in prestigious journals, underscoring his influence in the scientific community. Dr. Hashemzadeh’s work on the development of recombinant proteins and viral protein vaccines, as well as his significant contributions to the understanding of biological threat agents through nanotechnology, has earned him commendation. His dedication to advancing medical biotechnology and his role in pioneering research in cell therapy and genetic engineering reflect his outstanding contributions and make him a deserving candidate for further recognition and awards.

Conclusion

Dr. Mohammad Sadegh Hashemzadeh is a highly qualified candidate for the Research for Best Researcher Award, with a solid academic foundation, a track record of excellence in research, and contributions to medical biotechnology and nanotechnology. His continuous pursuit of innovative research and dedication to teaching underscore his suitability for this award. However, to further strengthen his candidacy, increased focus on collaborative research, securing research funding, and enhancing the practical application of his work could be beneficial.

Publications Top Notes

  1. Zinc Oxide Nanoparticles and Cancer Chemotherapy: Helpful Tools for Enhancing Chemo-sensitivity and Reducing Side Effects?
    • Authors: Vaghari-Tabari, M., Jafari-Gharabaghlou, D., Mohammadi, M., Hashemzadeh, M.S.
    • Journal: Biological Trace Element Research
    • Year: 2024
    • Volume and Issue: 202(5), pp. 1878–1900
    • Citations: 3
  2. Therapeutic Effects of IL-1RA, M2 Cells, and Their Synergistic Impact on a Mouse Model of Rheumatoid Arthritis
    • Authors: Hashemzadeh, M.S., Ghaleh, H.E.G., Mohammadi, M., Rezaei, E., Alishiri, G.
    • Journal: Advanced Pharmaceutical Bulletin
    • Year: 2024
    • Volume and Issue: 14(2), pp. 483–495
    • Citations: 0
  3. Correction: Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery (Journal of Genetic Engineering and Biotechnology, (2023), 21, 1, (20), 10.1186/s43141-023-00479-9)
    • Authors: Hashemzadeh, M.S., Gharari, N.
    • Journal: Journal of Genetic Engineering and Biotechnology
    • Year: 2023
    • Volume and Issue: 21(1), 40
    • Citations: 1
  4. Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery
    • Authors: Hashemzadeh, M.S., Gharari, N.
    • Journal: Journal of Genetic Engineering and Biotechnology
    • Year: 2023
    • Volume and Issue: 21(1), 20
    • Citations: 3
  5. Utilization of Freeze-Thawing Method for High-level Expression of Functional Human Epidermal Growth Factor (hEGF)
    • Authors: Mohammadi, M., Ghanbari, S., Emamgholi, A., Hashemzadeh, M.S.
    • Journal: International Journal of Peptide Research and Therapeutics
    • Year: 2023
    • Volume and Issue: 29(3), 38
    • Citations: 1
  6. Utilization of SUMO Tag and Freeze-thawing Method for a High-level Expression and Solubilization of Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) Protein in E. coli
    • Authors: Mohammadi, M., Taheri, R.A., Bemani, P., Farnoosh, G., Amini, R.
    • Journal: Protein and Peptide Letters
    • Year: 2022
    • Volume and Issue: 29(7), pp. 605–610
    • Citations: 4
  7. Evaluation of the acute and 28-day sub-acute intravenous toxicity of α-l-guluronic acid (ALG; G2013) in mice
    • Authors: Mahdian-Shakib, A., Hashemzadeh, M.S., Anissian, A., Oraei, M., Mirshafiey, A.
    • Journal: Drug and Chemical Toxicology
    • Year: 2022
    • Volume and Issue: 45(1), pp. 151–160
    • Citations: 6
  8. The role of bacterial superantigens in the immune response: From biology to cancer treatment
    • Authors: Hashemzadeh, M.S., Tapeh, B.E.G., Mirhosseini, S.A.
    • Journal: Current Cancer Therapy Reviews
    • Year: 2021
    • Volume and Issue: 17(1), pp. 21–34
    • Citations: 1
  9. Expression, solubilization, refolding and final purification of recombinant proteins as expressed in the form of “classical inclusion bodies” in e. coli
    • Authors: Hashemzadeh, M.S., Mohammadi, M., Ghaleh, H.E.G., Choopani, A., Panda, A.K.
    • Journal: Protein and Peptide Letters
    • Year: 2021
    • Volume and Issue: 28(2), pp. 2–10
    • Citations: 16
  10. Detection of West Nile virus by real-time PCR in crows in northern provinces of Iran
    • Authors: Sharti, M., Amouakbari, M.J., Pourjabari, K., Omidifar, A., Dorostkar, R.
    • Journal: Journal of Vector Borne Diseases
    • Year: 2020
    • Volume and Issue: 57(1), pp. 37–39
    • Citations: 2